Pregnancy Outcome After 131I Therapy

被引：0
|
作者：
Sioka, Chrissa [1 ]
Fotopoulos, Andreas [1 ]
机构：
[1] Univ Hosp Ioannina, Ioannina, Greece
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷 / 02期
关键词：
D O I：
10.2967/jnumed.108.055020
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：327 / 327
页数：1
相关论文
共 50 条
  • [31] ACCRETION OF 131I + TRIIODOTHYRONINE 131I BY RAT OVARY
    YATVIN, MB
    LEATHEM, JH
    ACTA ENDOCRINOLOGICA, 1964, 47 (01): : 144 - &
  • [32] Poor patient compliance with instructions for continuous sialogogues after 131I therapy
    Wu, Di
    Khorjekar, Gauri
    Kharazi, Pejman
    Moreau, Shari
    Kulkarni, Kanchan
    Burman, Kenneth D.
    Wartofsky, Leonard
    Van Nostrand, Douglas
    ORAL DISEASES, 2019, 25 (01) : 158 - 163
  • [33] Recommended restrictions after 131I therapy:: Measured doses in family members
    Mathieu, I
    Caussin, J
    Smeesters, P
    Wambersie, A
    Beckers, C
    HEALTH PHYSICS, 1999, 76 (02): : 129 - 136
  • [34] Vocal cord paralysis after 131I therapy for solitary toxic nodule
    Coover, LR
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (03) : 505 - 505
  • [35] Clinical outcome after treatment with 131I correlates with radiation sensitivity in hyperthyroidism patients
    Jia, X.
    Guo, K.
    Gao, R.
    Xue, J.
    Zhao, A.
    Yang, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S114 - S114
  • [36] Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents
    Mairs, RJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (08) : 1171 - 1173
  • [37] [131I]MIBG radionuclide therapy in carcinoid syndrome
    Taal, BG
    Zuetenhorst, H
    Olmos, RAV
    Hoefnagel, CA
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (03): : 243 - 243
  • [38] RADIATION THYROID CELLS AND 131I THERAPY - A HYPOTHESIS
    GREIG, WR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1965, 25 (10): : 1411 - +
  • [39] Study supports outpatient status for 131I therapy
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (06) : 28N - 28N
  • [40] Factors influencing the dosimetry and the therapeutic outcome of 131I therapy of differentiated thyroid cancer (DTC).
    Behr, TM
    Béhé, MP
    Gratz, S
    Hüfner, M
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 242P - 242P
12345